Skip to content

AcrySof® IQ PanOptix® Toric Trifocal IOL TFNT30 (REF TFNT30U195)Recalls & reported problems

Alcon Laboratories, Inc. · AcrySof® IQ PanOptix® Toric Trifocal intraocular lenses (IOLs) are ultraviolet absorbing and blue light filtering foldable multifocal IOLs · Class 3 · Implant

All models of AcrySof IQ PanOptix Toric Trifocal IOL (165)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00380652415514), received between Jun 7, 2021 and Aug 8, 2022 — classified as 4 injuries.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3
  • Device Dislodged or Dislocated1
  • Scratched Material1

Patient problems

  • Visual Impairment3
  • Blurred Vision2
  • Halo2
  • Visual Disturbances1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 8, 2022Device Dislodged or Dislocated; Scratched Material; Device Dislodged or Dislocated; Scratched Material

    A PHYSICIAN REPORTED FOLLOWING THE INTRAOCULAR LENS IMPLANTATION THE PATIENT HAD EXPERIENCED HALOS AND BLUR VISION. THE LENS WAS SLIGHTLY DISPLACED AND WAS SCRATCHED. THE LENS WAS EXPLANTED IN A SECONDARY PROCEDURE. PATIENT RECEIVED A REPLACEMENT LENS. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Blurred Vision; Halo; Visual Impairment

    MAUDE report 15183037 ↗
  • InjuryNov 4, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A NURSE REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT HAD OPTICAL SURPRISE. THE IOL EXCHANGED FOR ANOTHER LENS (ANOTHER MODEL) APPROXIMATELY ONE MONTH FOLLOWING THE INITIAL PROCEDURE.

    Patient problems: Visual Impairment

    MAUDE report 12750898 ↗
  • InjuryJul 1, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A FACILITY REPRESENTATIVE REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANTATION PROCEDURE, THE PATIENT EXPERIENCED DECREASED NEAR VISION, FIELD OF VISION DISTORTION, CONSTANT HAZY VISION PLUS GLARE AND HALOS. THE PATIENT WAS UNABLE TO ADAPT. ADDITIONAL INFORMATION WAS PROVIDED INDICATING THAT THE IOL WAS EXCHANGED FOR A DIFFERENT IOL MODEL.

    Patient problems: Blurred Vision; Halo; Visual Disturbances

    MAUDE report 12100835 ↗
  • InjuryJun 7, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PHYSICIAN REPORTED THAT AFTER AN INTRAOCULAR LENS WAS IMPLANTED, THE PATIENT EXPERIENCED VISUAL SIDE EFFECTS. THE LENS WAS EXCHANGED FOR A DIFFERENT LENS 5 MONTHS AFTER INITIAL IMPLANTATION. INTOLERANT TO MONOFOCAL , VISUAL DISTURBANCE WAS THE CLINICAL REASON GIVEN FOR THE EXPLANT. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: Visual Impairment

    MAUDE report 11951463 ↗

Other Lens, multifocal intraocular devices

All Lens, multifocal intraocular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page